Grifols International, S.A.

October 16, 2020

Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with a long-term experience in producing intravenous solutions for the pharmaceutical industry worldwide.

Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with a long-term experience in producing intravenous solutions for the pharmaceutical industry worldwide.

Over the years we have established successful relationships with customers in global markets, including North America, Canada, Australia, and Europe in the following areas:

• Human & Veterinary fields

• New product development

• Generic drug development and manufacturing

Grifols Partnership has two FDA and GMP approved manufacturing facilities in Spain for intravenous solutions that have parametric release certification.

Major products/services

We specialize in small molecule intravenous solutions and offer high quality pharmaceutical development and product manufacturing. Our portfolio also includes products which require careful design and assembly including medical devices and bags for blood storage and collection.

Technological capabilities:

• Drug Product Development

• Small Molecule Drug Products

• Terminal Sterilization

• Light and O2 sensitive products

• Emulsion Technology

• Vials (5 to 50 mL)

• Diluents

• Glass Bottles (50 to 500 mL)

• Flexible Containers (PP bags, 50 to 1000 mL)

• FFS technology for PP bags

• Regulatory Approvals

Grifols International, S.A.
Address: Av. de la Generalitat, 152-158, 08174 Sant Cugat del Vallès, Barcelona, Spain
Tel. +34935712199
Fax: +34935710474
partnership@grifols.com
www.partnership.grifols.com